Round table on RU486.
Shallat
L
L
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001695:Biology; D019049:Developed Countries; D003906:Developing Countries; D004703:Endocrine System; D004989:Ethics; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D019513:Feminism; D005602:France; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone; D010827:Physiology; D011057:Politics
D000019:Abortifacient Agents; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Biology; Critique; Developed Countries; Developing Countries; Endocrine System; Ethics; Europe; Family Planning; Feminism; Fertility Control, Postconception; France; Hormone Antagonists; Hormones; Mediterranean Countries; Physiology; Political Factors; Ru-486--indications; Ru-486--therapeutic use; Western Europe